Kolltan Pharmaceuticals, a privately held biopharmaceutical company focused on the development of novel biologics targeting receptor tyrosine kinases, today announced key developments within its leadership team. The Company has appointed Jane Henderson to the newly established position of Senior Vice President, Chief Financial and Business Officer, effective immediately.
Help employers find you! Check out all the jobs and post your resume.
